We are live on ! Find out more

Enavate Sciences Portfolio holdings

AUM $345M Turnover 0%

1-Year Est. Return 134.64%

This Fund

S&P 500

This Quarter Est. Return

+44.71%

1 Year Est. Return

+134.64%

3 Year Est. Return

–

5 Year Est. Return

–

10 Year Est. Return

–

AUM

$177M

AUM Growth

+$43.8M (+33%)

Cap. Flow

Cap. Flow % of AUM Cap. Flow %

Top 10 Holdings % Top 10 Hldgs %

100%

Holding

New

–

Increased

–

Reduced

–

Closed

–

Avg Time Held

0.5 years

Top 10 Avg Time Held

0.5 years

Top 20 Avg Time Held

0.5 years

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank	Sector	Weight
1	Healthcare	100%

Communication Services

Advertising Agencies

Broadcasting

Electronic Gaming & Multimedia

Entertainment

Internet Content & Information

Publishing

Telecom Services

Consumer Discretionary

Apparel Manufacturing

Apparel Retail

Auto Manufacturers

Auto Parts

Auto & Truck Dealerships

Department Stores

Footwear & Accessories

Furnishings, Fixtures & Appliances

Gambling

Home Improvement Retail

Internet Retail

Leisure

Lodging

Luxury Goods

Packaging & Containers

Personal Services

Recreational Vehicles

Residential Construction

Resorts & Casinos

Restaurants

Specialty Retail

Textile Manufacturing

Travel Services

Consumer Staples

Beverages - Brewers

Beverages - Non-Alcoholic

Beverages - Wineries & Distilleries

Confectioners

Discount Stores

Education & Training Services

Farm Products

Food Distribution

Grocery Stores

Household & Personal Products

Packaged Foods

Tobacco

Energy

Oil & Gas Drilling

Oil & Gas Equipment & Services

Oil & Gas Exploration & Production

Oil & Gas Integrated

Oil & Gas Midstream

Oil & Gas Refining & Marketing

Thermal Coal

Uranium

Financials

Asset Management

Banks - Diversified

Banks - Regional

Capital Markets

Credit Services

Diversified Insurance

Financial Conglomerates

Financial Data & Stock Exchanges

Insurance Brokers

Life Insurance

Mortgage Finance

Property & Casualty Insurance

Reinsurance

Shell Companies

Specialty - Insurance

Healthcare

Biotechnology

Diagnostics & Research

Drug Manufacturers - General

Drug Manufacturers - Specialty & Generic

Healthcare Plans

Health Information Services

Medical Care Facilities

Medical Devices

Medical Distribution

Medical Instruments & Supplies

Pharmaceutical Retailers

Industrials

Aerospace & Defense

Airlines

Airports & Air Services

Building Products & Equipment

Business Equipment & Supplies

Conglomerates

Consulting Services

Electrical Equipment & Parts

Engineering & Construction

Farm & Heavy Construction Machinery

Industrial Distribution

Infrastructure Operations

Integrated Freight & Logistics

Marine Shipping

Metal Fabrication

Pollution & Treatment Controls

Railroads

Rental & Leasing Services

Security & Protection Services

Specialty Business Services

Specialty Industrial Machinery

Staffing & Employment Services

Tools & Accessories

Trucking

Waste Management

Materials

Agricultural Inputs

Aluminum

Building Materials

Chemicals

Coking Coal

Copper

Gold

Lumber & Wood Production

Other Industrial Metals & Mining

Other Precious Metals & Mining

Paper & Paper Products

Silver

Specialty Chemicals

Steel

Real Estate

Diversified REIT

Healthcare Facilities REIT

Hotel & Motel REIT

Industrial REIT

Mortgage REIT

Office REIT

Real Estate Development

Real Estate Diversified

Real Estate Services

Residential REIT

Retail REIT

Specialty REIT

Technology

Communication Equipment

Computer Hardware

Consumer Electronics

Electronic Components

Electronics & Computer Distribution

Information Technology Services

Scientific & Technical Instruments

Semiconductor Equipment & Materials

Semiconductors

Software - Application

Software - Infrastructure

Solar

Utilities

Diversified Utilities

Electric Utilities

Gas Utilities

Independent Power Producers

Renewable Electricity

Water Utilities

#	Name	Market Value	Portfolio Weight	Shares or Principal	Change in Stake	Capital Flow	Held Since
1	1 Immunome IMNM $2.15B	$44.3M	25.12%	4,768,583	–	–	2024 Q4 2 quarters
2	2 Sionna Therapeutics SION $175M	$43M	24.35%	2,478,030	–	–	2025 Q1 1 quarter
3	3 Zenas BioPharma ZBIO $1.85B	$36.4M	20.65%	3,761,359	–	–	2024 Q4 2 quarters
4	4 Upstream Bio Inc UPB $187M	$27M	15.3%	2,459,703	–	–	2024 Q4 2 quarters
5	5 Compass Therapeutics CMPX $142M	$20.2M	11.47%	7,788,150	–	–	2024 Q4 2 quarters
6	6 CAMP4 Therapeutics CAMP $249M	$5.49M	3.11%	3,785,802	–	–	2024 Q4 2 quarters

Similar funds

LCM

Lonestar Capital Management San Francisco, California $345M AUM 80.24% 1-Year Est. Return

Matthew 25 Management Corp Ambler, Pennsylvania $345M AUM 31.27% 1-Year Est. Return

Front Row Advisors Tiburon, California $345M AUM 39.04% 1-Year Est. Return

Muhlenkamp & Co Wexford, Pennsylvania $345M AUM 34.25% 1-Year Est. Return

Bear Mountain Capital Seattle, Washington $345M AUM 13.71% 1-Year Est. Return

RR Advisors Dallas, Texas $346M AUM 31.14% 1-Year Est. Return

WFI

West Family Investments Carlsbad, California $345M AUM 46.29% 1-Year Est. Return

Sender Company & Partners New York $345M AUM 41.88% 1-Year Est. Return

Enavate Sciences's Q2 2025 Portfolio in Review

As of Q2 2025, Enavate Sciences held 6 positions worth $177M, up 33% from $133M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Enavate Sciences opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Enavate Sciences's ten largest holdings make up 100% of its $177M portfolio in Q2 2025.
Enavate Sciences opened 0 new positions and closed 0 in Q2 2025.
Enavate Sciences's portfolio value rose 33% quarter-over-quarter to $177M.

Based on Enavate Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.